conference reports
Robotic surgery may alter radiation planning in prostate cancer therapy
Thursday, 11 March 2010- Robot-assisted surgery for prostate cancer may require alteration in radiation planning but doesn't preclude sufficient lymph node sampling, according to results of two studies presented at the ASCO...
Edited by: JV
Most skeletal-related events due to bony metastases
Tuesday, 8 March 2010- Skeletal-related events (SREs) in patients with metastatic hormone-refractory prostate cancer (mHRPC) are mostly due to bony metastatic disease and not decreased bone mineral density (BMD), according to...
Edited by: ES
7th ESOU Meeting: Key messages, prostate cancer session
Friday, 15 January 2010- From focal therapy, radiotherapy to surgical options such as robot-assisted prostatectomy, a range of issues, controversies and challenges in prostate cancer were discussed in the opening plenary session...
By Joel Vega
Efficacy in PCa of SBRT hypofractionated regime treatment with CyberKnife
Monday, 28 December 2009- A group of Italian researchers reported their initial experience with Hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) through CyberKnife® to show its safety and feasibility as a treatment...
Edited by: Joel Vega
Undetectable PSA possible with radiation
Monday, 14 December 2009- Improved radiotherapy techniques have made it possible for men to achieve reductions in PSA to below detectable levels following radiation treatment for prostate cancer, according to new findings...
Edited by: ES
EMUC Debate: pro and contra arguments on mass PCa screening
Friday, 11 December 2009- Pro and contra arguments on the benefits of prostate cancer screening were presented during the recent 2nd European Multidisciplinary Meeting on Urological Cancers (EMUC) with both camps debating a...
By Joel Vega
Coffee consumption linked to reduced risk of advanced prostate cancer
Wednesday, 9 December 2009- While it is too early for physicians to start advising their male patients to take up the habit of regular coffee drinking, data presented at the American Association for Cancer Research Frontiers in...
Edited by: ES
Autologous tumor cell vaccine induces cellular immune response in patients with PCa
Tuesday, 8 November 2009- Autologous tumour cell vaccine could be a good alternative therapeutic strategy in the management of patients with advanced stage prostate cancer, suggests a new study, the results of which were...
Edited by: ES
Abiraterone acetate well tolerated and safe in selected patients
Monday, 7 December 2009- Delayed toxicity following abiraterone acetate (AA) treatment is uncommon in patient population with advanced castration resistant prostate cancer and can be safely administered for long periods...
Edited by: ES
Hypofractionation vs. conventional fractionation RT in high-risk PCa patients
Thursday, 3 December 2009- Early results of a phase 3 study examining hypofractionation radiotherapy in high-risk prostate cancer patients showed that the hypofractionated schedule is superior than conventional fractionation in...
Edited by: Joel Vega
